TABLE 1.
Characteristics of the study populations
| Group | Number | Racial distribution
|
Age (mean±sd) | Medical conditions | ||
|---|---|---|---|---|---|---|
| Ca | A-A | As | ||||
| I | No inflammatory or infectious problems | |||||
| Male | 15 | 11 | 3 | 1 | 72.4 ± 4.3 | |
| Female | 13 | 11 | 1 | 1 | 75.6 ± 7.9 | |
| IIA | ||||||
| Male | 5 | 5 | 0 | 0 | 70.6 ± 5.7 | I(2), L(3), A(2), C(2), H(1) |
| Female | 6 | 4 | 1 | 1 | 74.2 ± 5.8 | I(4), L(1), A(3), T(1) |
| IIB | ||||||
| Male | 5 | 4 | 1 | 0 | 69.2 ± 3.7 | I(4), IL(3), L(1), H(2) |
| Female | 6 | 6 | 0 | 0 | 69.7 ± 4.3 | I(3), Rh(4), L(2), T(1) |
Group I, healthy; group IIA, mild infections and/or inflammatory disease; group IIB, autoimmunity and/or severe infections; Ca, Caucasian; A-A, African-American; As, Asian; I, infections; L, lymphopenia; A, inflammatory osteoarthritis; C, recent cancer; H, hypogammaglobulinemia; T, thyroiditis; IL, inflammatory lung disease; Rh, multiple sclerosis, rheumatoid arthritis, and/or uveitis.